MOTS-c and NAD+ Cellular Energy Research

NextGen Peptides Research Library

Mitochondrial and redox research | 7 min read | Updated October 11, 2026

MOTS-c and NAD+ are both discussed in cellular-energy research, but they are not the same kind of molecule. MOTS-c is a mitochondrial-derived peptide studied as a signaling molecule. NAD+ is a central redox coenzyme and enzyme substrate involved in energy metabolism, DNA repair signaling, sirtuin activity, PARP activity, and broader cellular stress responses.

Research and educational use only. This article does not provide medical advice, dosing guidance, or a recommendation for human or veterinary use. Research findings discussed below do not establish clinical benefits for research-use catalog products.

At a glance

• MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded within mitochondrial DNA.
• The original Cell Metabolism work reported metabolic-homeostasis effects in cell and animal models.
• Human research has reported exercise-related changes in endogenous MOTS-c expression, but that is not the same as proving supplementation effects.
• NAD+ is a redox coenzyme central to energy metabolism and also supports signaling enzymes involved in DNA repair, chromatin, and stress-response biology.

What MOTS-c is

MOTS-c stands for mitochondrial open reading frame of the 12S rRNA-c. It is one of the best-known mitochondrial-derived peptides. The 2015 Cell Metabolism paper that introduced MOTS-c reported that the peptide helped regulate metabolic homeostasis in experimental systems, with skeletal muscle and AMPK-related pathways receiving particular attention.

The important point is that MOTS-c belongs to a newer research area: mitochondria are not only power producers, but also signaling hubs. Mitochondrial-derived peptides are one way mitochondria may communicate cellular energy state to the nucleus and other tissues.

What NAD+ is

NAD+ is nicotinamide adenine dinucleotide. It cycles between oxidized NAD+ and reduced NADH forms, making it central to redox reactions in energy metabolism. NAD+ is also consumed by enzyme systems such as sirtuins, PARPs, and CD38-related pathways. That makes it relevant to research on mitochondrial function, DNA repair signaling, chromatin regulation, immune-cell activity, and aging biology.

Unlike MOTS-c, NAD+ is not a peptide. It is a coenzyme. That distinction matters when comparing product categories, storage expectations, and research questions.

Where the evidence is strongest

MOTS-c: The strongest evidence is mechanistic and preclinical. The original Cell Metabolism study reported effects in cultured cells and mice, including AMPK-associated signaling, skeletal-muscle metabolic changes, and resistance to diet-induced metabolic disruption in the tested animal model. Later research and reviews discuss stress adaptation, mitochondrial communication, and age-related physiology. Human exercise studies suggest endogenous MOTS-c expression changes with exercise, but that does not prove clinical effects from a research material.

NAD+: The evidence is strongest for its core biochemical role. NAD+ is essential for redox chemistry and cellular metabolism, and it is also consumed by enzymes involved in DNA-repair signaling, chromatin regulation, and stress-response pathways. The translational question is harder: changing NAD+ levels in specific tissues, compartments, and disease contexts is complex, and reviews repeatedly emphasize that timing, cell type, dose, and biological context matter.

Why researchers connect these topics

MOTS-c and NAD+ both sit close to mitochondrial-energy research, but from different angles. MOTS-c is studied as a signal. NAD+ is studied as a redox and enzyme-substrate hub. Both intersect with AMPK, mitochondrial homeostasis, oxidative stress, cellular aging models, and metabolic-stress pathways.

That overlap is why people often search these topics together. It is also why the difference should be explained clearly on a research site: one is a mitochondrial-derived peptide, the other is a core coenzyme.

What COAs can verify

For catalog products, documentation should focus on identity, purity, batch or lot number, test date, analytical method, and report details. A COA can support analytical traceability. It cannot prove mitochondrial effects, energy changes, anti-aging outcomes, exercise benefits, or human safety.

Common misinterpretations to avoid

• “Energy research” does not mean stimulant effect. Cellular-energy biology is about pathways and metabolism, not a guaranteed feeling.
• Endogenous MOTS-c changes after exercise do not prove exogenous product effects. Those are different research questions.
• NAD+ biology is context-dependent. A molecule can be central to metabolism without every intervention being beneficial in every tissue or condition.
• Research-use documentation is not clinical validation. COAs and lab reports verify analytical details, not human outcomes.

Bottom line

MOTS-c and NAD+ are both important in mitochondrial and cellular-energy research, but they should be described accurately. MOTS-c is a mitochondrial-derived peptide studied for signaling and metabolic-homeostasis pathways. NAD+ is a redox coenzyme and signaling substrate central to cellular metabolism. For research catalog pages, the strongest presentation is clear identity, batch documentation, storage guidance, and honest separation between mechanistic research and human-use claims.

Sources

1. Lee C et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015.
2. D’Souza RF et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications. 2021.
3. Wan J et al. Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging. Journal of Translational Medicine. 2023.
4. Covarrubias AJ et al. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. 2021.
5. Recent review literature on regulation and challenges in targeting NAD+ metabolism. Nature Reviews Molecular Cell Biology. 2024.

Editorial standard: This article is written for research education and catalog context. It explains mechanistic findings clearly while keeping product documentation, storage, and research-use limits separate from clinical claims.